Human Papillomavirus Vaccine Is Crucial for Adolescent and Young Adult Cancer Survivors

Soliman H , Agresta SV . Current issues in adolescent and young adult cancer survivorship. Cancer Control. 2008; 15(1):55–62.

Patterson P , et al. Emerging issues among adolescent and young adult cancer survivors. Semin Oncol Nurs. 2015; 31(1):53–9.

Chesson HW , et al. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014; 41(11):660–4.

Cogliano V , et al. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005; 6(4):204.

Satterwhite CL , et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013; 40(3):187–93.

Ojha RP , et al. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One. 2013; 8(8):e70349.

Brickman C , Palefsky JM . Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era. Curr HIV/AIDS Rep. 2015; 12(1):6–15.

Bhatia S , et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001; 19(2):464–71.

Viens LJ , et al. Human papillomavirus-associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016; 65(26):661–6.

Beutner KR , et al. External genital warts: report of the American Medical Association Consensus Conference. AMA expert panel on external genital warts. Clin Infect Dis., 1998; 27(4):796–806.

Markowitz LE , et al. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016; 137(3):e20151968.

Reagan-Steiner S , et al. National, regional, state, and selected local area vaccination coverage among adolescents Aged 13–17 Years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016; 65(33):850–8.

Williams WW , et al. Surveillance of vaccination coverage among adult populations—United States, 2014. MMWR Surveill Summ. 2016; 65:1–36.

Klosky JL , et al. Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer. J Cancer Surviv. 2016; 10(3):449–56.

Klosky JL , et al. Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Pediatr Blood Cancer. 2015; 62(9):1630–6.

Hoffman L , et al. Human papillomavirus vaccination in female pediatric cancer survivors. J Pediatr Adolesc Gynecol. 2012; 25(5):305–7.

McBride ML , et al. Patterns of physician follow-up among young cancer survivors: report of the childhood, adolescent, and young adult cancer survivors (CAYACS) research program. Can Fam Physician. 2011; 57(12):e482–90.

Klosky JL , et al. Risky sexual behavior in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. Health Psychol. 2014; 33(8):868–77.

Thompson K , et al. An exploratory study of oncology specialists' understanding of the preferences of young people living with cancer. Soc Work Health Care. 2013; 52(2–3):166–90.

Rendle KA , Leskinen EA . Timing is everything: exploring parental decisions to delay HPV vaccination. Qual Health Res. 2016.

Liddon N , et al. Maternal underestimation of child's sexual experience: suggested implications for HPV vaccine uptake at recommended ages. J Adolesc Health. 2013; 53(5):674–6.

Kann L , et al. Youth risk behavior surveillance—United States, 2015. MMWR Surveill Summ. 2016; 65(6):1–174.

Kasting ML , et al. Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research. Hum Vaccin Immunother. 2016; 12(6):1435–50.

Petrosky E , et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015; 64(11):300–4.

HPV vaccine recommendations. Pediatrics. 2012; 129(3):602–5.

Bailey HH , et al. American society of clinical oncology statement: human papillomavirus vaccination for cancer prevention. J Clin Oncol. 2016; 34:1803–12.

Saslow D , et al. Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement. CA Cancer J Clin. 2016; 66(5):375–85.

Robinson CL . Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2016; 65(4):86–7.

Kim DK , Bridges CB , Harriman KH . Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older—United States, 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(4):91–2.